Topic Archives: Leucadia (LUK)

This is not a fundamental look at any of these stocks, but just a quick update on my personal portfolio. Like you, I have many priorities in my life… and some of those priorities changed a bit over the last week or two, so we’re considering some real estate transactions that make it important for […]

Each year I go through all of the stocks that I either own personally or have brought to the attention of the Irregulars (there’s quite a bit of overlap on those lists), and I make sure to update my thoughts and opinion on that stock in an organized and, hopefully, disciplined way — that helps […]

More “Contrarian Bonanza” picks, you ask? Well of course! There are several new teaser ads stacking up in the Thinkolator’s inbox, but before we get to those … let’s close the book on the “contrarian bonanza” picks from the Weiss folks as they tease their Million-Dollar Contrarian Portfolio. There are three left of the seven […]

Comments

  • Avatar

    I believe its the same pitch Travis has already wrote about, Bellicum Pharmaceuticals https://www.stockgumshoe.com/r...

  • SoGiAm

    A friend is someone with whom you dare to be yourself. ~ Frank Crane Immunotherapy has been the most exciting advance...

  • Avatar

    BELLICUM PHARMACEUTICALS INC COM BLCM: NASDAQ...

  • Avatar

    I'm new to Gumshoe and this thread. Just wanted to ask if anyone has knowledge of Lexagene Holdings Inc. (LXXGF) and/or...

  • Avatar

    Hey gumshoe bellicum pharmaceuticals was supposed to announce a licensing deal today either with Novartis or glaxo Smith...

  • Avatar

    See the following article at Yahoo.com Finance: Here's Why Bellicum Pharmaceuticals Fell as Much as 13.8% Today...

  • Avatar

    This is just now: BLCM Bellicum Pharmaceuticals Inc $0.20 (1.52%) $20.00 $49.05 (3.82%) MBRX Moleculin...

  • Avatar

    The BLCM goes up again today: BLCM Bellicum Pharmaceuticals Inc 100 $1,284.95 $12.85 $13.55 $0.19 (1.42%) ...

  • Avatar

    New Clinical Trial Review: Leukemia Patients Treated by Bellicum Pharmaceuticals -- 91% remission, 94% Survival (median ...

  • Avatar

    Bellicum Pharmaceuticals Inc BLCM....

  • Avatar

    Annemarie Moseley Bellicum Pharmaceuticals Inc.,Houston,United States Speaker of (S146) BPX-501 DONOR T CELL INFUSI...

  • Avatar

    John Weinberg Bellicum Pharmaceuticals Inc.,Houston,United States Speaker of (S146) BPX-501 DONOR T CELL INFUSION (...

  • Avatar

    Nov. 1, 2016-- Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM) and Ospedale Pediatrico Bambino Gesù (OPBG), a leading Euro...

  • Avatar

    I've noticed some confusion about the nature of the $388,000 in this thread. The $388,000 is in relation to their 2016 f...

  • Avatar

    Maybe helpful? Maybe someone can help confirm relevance? All accepted abstracts of the 22nd Congress are now publishe...

  • Avatar

    This is a bit of an aside, but I've been thinking of putting together a tracking index of the biotechs followed here. W...

  • DrKSSMDPhD

    Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and deve...

  • SoGiAm

    Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a clinical stage biopharmaceutical company focused on discovering and deve...

  • Avatar

    A take on Juno Therapeutics (JUNO) and Bellicum Pharmaceuticals (BLCM). http://www.fool.com/investing/general/2015/01/2...

  • Avatar

    RE:BLCM Bellicum Pharmaceuticals Announces Successful Dosing of First Patient Cohort With BPX-501 T Cells Following Hap...

  • Avatar

    KSS the Magical Marvelous (De)Mystifying Tour Guide: You mentioned Bellicum Pharmaceuticals ($BLCM) as, "a new immuno...

  • DrKSSMDPhD

    Bellicum Pharmaceuticals ($BLCM) is a new immuno-onc play with designs on T-cell mediated tumor kill by distinct approac...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info